Pall has registered a patent with the US Patent and Trademark Office (USPTO) regarding its disposable, closed cell collection and seeding system used for vein regeneration procedures.
The new technology is used to isolate and collect patient’s mononuclear cells which are then implanted to a bioengineered grafts in patients with congenital heart defects to replace damaged or missing blood vessels.
Pall Medical president Byron Selman said since the system is pre-connected and completely closed, the entire process can be started and completed right next to the operating table, eliminating the need for a clean room and limiting the possibility of contamination.